A British drug company is a step closer to launching cannabis-based medicine for patients suffering multiple sclerosis and other forms of severe pain
Share this Story
A British drug company is a step closer to launching cannabis-based medicine for patients suffering multiple sclerosis and other forms of severe pain
Plasmapheresis — originally uploaded by Red Wolf